Regen BioPharma Inc (RGBP)

[gotinearly]

SUMMARY OF DCELLVAX PROGRESS (UPDATED OCT 2014):

Canadian Trader---Worth re-posting

Feb 26, 2013 - BMSN announce Letter of Intent (LOI) to acquire WP Min cancer gene-silencing intellectual property.
http://ih.advfn.com/p.php?pid=nmona&article=56463068

Apr 4, 2013 - Update about pre-clinical and clinical programs; planned IND submission for Q4 2013.
http://ih.advfn.com/p.php?pid=nmona&article=57035344

May 6, 2013 - Regen officially acquires WP Min cancer gene-silencing therapy patent; will focus efforts on breast cancer.
http://ih.advfn.com/p.php?pid=nmona&article=57439657

Aug 8, 2013 - Regen licenses cancer gene-silencing therapy from Benitec BioPharma; demonstrates its action on IDO in dendritic cells.
http://ih.advfn.com/p.php?pid=nmona&article=58739425

Aug 16, 2013 - Conducting toxicity experiments using WP Min and Benitec technologies; reiterates planned submission of IND by Q4 2013.
http://ih.advfn.com/p.php?pid=nmona&article=58853168

Sept 17, 2013 - BMSN recruit Dr. David Suhy to Regen advisory board; his experience in RNAi is useful for Regen's cancer therapy.
http://ih.advfn.com/p.php?pid=nmona&article=59244933

Sept 25, 2013 - Announcement of "dCellVax" breast cancer immunotherapeutic product; outline further 8 months of milestones.
http://ih.advfn.com/p.php?pid=nmona&article=59354656

Jun 11, 2014 - Announce research paper on the use of gene-silencing in heart transplants, showing multiple applications of dCellVax technology; dCellVax IND planned for August 2014.
http://ih.advfn.com/p.php?pid=nmona&article=62529632

Aug 1, 2014 - Update on dCellVax progress; Regen successfully achieves silencing of the IDO gene in human dendritic cells ahead of expected IND submission.
http://www.marketwatch.com/story/regen-biopharma-provides-update-on-dcellvax-breast-cancer-immunotherapy-2014-08-01

Sept 16, 2014 - Regen announce patent filing for novel means of cancer immunotherapy; basis of dCellVax.
http://www.marketwatch.com/story/regen-biopharma-files-patent-application-on-new-therapy-that-uses-the-innate-immune-system-to-kill-cancer-2014-09-16

Oct 1, 2014 - Regen completes preclinical experiments, begins preparation of IND application.
http://www.marketwired.com/press-release/regen-biopharma-completes-preclinical-experiments-dcellvax-breast-cancer-immune-therapy-otcbb-rgbp-1952694.htm

Oct 8, 2014 - Regen files dCellVax IND.
http://www.marketwired.com/press-release/regen-biopharma-inc-files-ind-application-with-fda-dcellvax-breast-cancer-immune-therapy-otcbb-rgbp-1955886.htm

** All dates listed above refer to the date of the linked PR **


For further Regen BioPharma timelines, please see my post on HemaXellerate I progress: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=106944954

$$ RGBP BMSN $$